The analysis of the immunofluorescence with TRPM showed that the expression of this protein was induced by the treatment of CML-BSA versus the control group, but such effect was suppressed by the inhibitory action of RAGE (Figure 1(b)). This evidence concerns the gene AGER and chronic myelogenous leukemia, BCR-ABL1 positive.